FGFR4 and hepatocellular carcinoma: Tumor growth in SOX18-induced HCC metastasis was significantly inhibited after treatment with BLU-9931, a selective FGFR4 inhibitor, which indicates the significance of FGFR4 in metastatic HCC [77,78].